Health-related quality of life outcomes for patients with immune thrombocytopenic purpura

Klaassen, Robert J.; Young, Nancy L.
July 2010
Annals of Hematology;Jul2010, Vol. 89, p51
Academic Journal
journal article
Immune thrombocytopenic purpura (ITP) is a rare disease with infrequent serious bleeding making clinical trials difficult. One solution to this problem is to use alternative outcome measures such as health-related quality of life (HRQL). This review describes the various HRQL tools available to researchers including measures that are generic (applicable to many different disease types) and disease-specific measures developed explicitly for ITP specifically detailing the Kids' ITP Tools and the ITP-patient administered questionnaire. This review describes how incorporating HRQL tools such as these will allow researchers to move forward and do methodologically sound research.


Related Articles

  • Agents to Control Bleeding Show Promise. Hampton, Tracy // JAMA: Journal of the American Medical Association;1/24/2007, Vol. 297 Issue 4, p349 

    The article describes clinical trials that examined the use of anticoagulants to prevent bleeding in patients at risk of venous thrombolism who are treated with anticoagulants and in patients with thrombocytopenia. A trial funded by Sanofi-Aventis studied the use of the anticoagulant idraparinux...

  • Eltrombopag RAISEs the bar in ITP.  // PharmacoEconomics & Outcomes News;8/8/2009, Issue 584, p9 

    The article deals with a study presented at the 14th Congress of the European Hematology Association which showed that the thrombopoietin receptor agonist eltrombopag has a positive impact on quality of life (QOL) in patients with idiopathic thrombocytopenia purpura (ITP). The study found that...

  • The working group for “basic science” in ITP at the International Cooperative ITP Study Group (ICIS). Clemetson, Kenneth J.; Panzer, Simon // Annals of Hematology;Jul2010, Vol. 89, p3 

    A variety of studies were considered necessary to better understand the etiology of idiopathic thrombocytopenic purpura. Apoptosis of platelets and megakaryocytes were strong proposals, calling for collaboration. Some groups want to study microparticles and thombin generation in order to...

  • Platelet Survival and Sequestration Studies in Idiopathic Thrombocytopenic Purpura. Murphy, Scott; Gardner, Frank H. // Annals of Internal Medicine;Jun74, Vol. 80 Issue 6, p768 

    Comments on a study concerning the proper management of adult patients with idiopathic thrombocytopenic purpura. Diagnosis of idiopathic thrombocytopenic purpura; Importance for patients to have kinetic studies with chromium-labeled platelets; Complete remission after splenectomy in all...

  • Splenectomy for Idiopathic Thrombocytopenic Purpura: A Five-Year Retrospective Review. Gibson, Michael; Sehon, J. Kenneth; White, Stephen; Zibari, Gazi B.; Johnson, Lester W. // American Surgeon;Oct2000, Vol. 66 Issue 10, p952 

    Idiopathic thrombocytopenic purpura is a condition that is characterized by persistently low platelet counts. Idiopathic thrombocytopenic purpura results from splenic sequestration and accelerated platelet destruction mediated by antiplatelet antibody. Most cases arise in previously healthy...

  • Fatal Immune Thrombocytopenia Induced by Ethchlorvynol. Jacobson, Eric S. // Annals of Internal Medicine;Jul72, Vol. 77 Issue 1, p73 

    Describes a case of immune thrombocytopenic purpura induced by ethchlorvynol. Medical background of the patient; Findings of the clot retraction studies.

  • Thrombocytopenia and Intravenous Heroin Use. Adams, William H.; Rufo, Robert A.; Talarico, Lilia; Silverman, Stuart L.; Brauer, Mark J. // Annals of Internal Medicine;Aug78, Vol. 89 Issue 2, p207 

    Focuses on a study which dealt with the case of a male heroin user with a syndrome similar to acute immune thrombocytopenic purpura. Epidemiologic considerations of the illness; Results of hematologic laboratory tests; Reasons for the suspicion of toxic basis for thrombocytopenia.

  • Photo Quiz. Berger, Marc S. // American Family Physician;9/1/1999, Vol. 60 Issue 3, p927 

    Presents a case of a 30-year-old man with idiopathic thrombocytopenic purpura (ITP) and idiopathic constrictive pericarditis. Clinical presentation; Diagnosis; Explanation on the diagnosis.

  • Accessory Splenectomy in the Management of Recurrent Immune Thrombocytopenic Purpura. Walters, David N.; Roberts, Jerry L.; Votaw, May // American Surgeon;Nov1998, Vol. 64 Issue 11, p1077 

    Describes a case of recurrent thrombocytopenia associated with an accessory spleen occurring 5 years after splenectomy in a young woman with chronic immune thrombocytopenic purpura (ITP). Causes of failures of splenectomy; Success of accessory splenectomy in producing a sustained remission;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics